Document:

Exhibit

Exhibit 10.3
AMENDMENT NUMBER THIRTEEN
to the
SECOND AMENDED AND RESTATED  
MASTER REPURCHASE AGREEMENT
dated as of January 29, 2016
between
BARCLAYS BANK PLC
and
NATIONSTAR MORTGAGE LLC
This AMENDMENT NUMBER THIRTEEN (this “Amendment”) is made as of this 30th day of March, 2020, by and between Barclays Bank PLC (“Purchaser” and “Agent”) and Nationstar Mortgage LLC (“Seller”), to that certain Second Amended and Restated Master Repurchase Agreement, dated as of January 29, 2016 (as amended by that certain Amendment Number One to the Second Amended and Restated Master Repurchase Agreement, dated as of June 24, 2016, Amendment Number Two to the Second Amended and Restated Master Repurchase Agreement, dated as of October 17, 2016, Amendment Number Three to the Second Amended and Restated Master Repurchase Agreement, dated as of October 31, 2016, Amendment Number Four to the Second Amended and Restated Master Repurchase Agreement, dated as of October 30, 2017, Amendment Number Five to the Second Amended and Restated Master Repurchase Agreement, dated as of March 22, 2018, Amendment Number Six to the Second Amended and Restated Master Repurchase Agreement, dated as of May 29, 2018, Amendment Number Seven to the Second Amended and Restated Master Repurchase Agreement, dated as of October 24, 2018, Amendment Number Eight to the Second Amended and Restated Master Repurchase Agreement, dated as of November 20, 2018, Amendment Number Nine to the Second Amended and Restated Master Repurchase Agreement, dated as of January 28, 2019, Amendment Number Ten to the Second Amended and Restated Master Repurchase Agreement, dated as of March 29, 2019, Amendment Number Eleven to the Second Amended and Restated Master Repurchase Agreement, dated as of April 3, 2019, and Amendment Number Twelve to the Second Amended and Restated Master Repurchase Agreement, dated as of October 25, 2019, and as further amended, restated, supplemented or otherwise modified from time to time, the “Repurchase Agreement”), by and among Seller, Agent and Purchaser.
WHEREAS, Purchaser, Agent and Seller have agreed to amend the Repurchase Agreement as more particularly set forth herein;
NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and for the mutual covenants herein contained, the parties hereto hereby agree as follows:  
SECTION 1.Amendment. Effective as of the Effective Date, the Repurchase Agreement is hereby amended as follows:
(a)    Section 2(a) of the Repurchase Agreement is hereby amended by deleting the defined term “Maturity Date” in its entirety and replacing it with the following:
 “Maturity Date” means April 5, 2021.

(b)    The defined terms “Non-Qualified Mortgage Loan” and “Second Lien Mortgage Loan” in Section 2(a) of the Repurchase Agreement are hereby deleted, and all textual references in the Repurchase Agreement relating to Non-Qualified Mortgage Loans or Second Lien Mortgage Loans are hereby deleted. In addition, Exhibit B-2 is hereby deleted from the Repurchase Agreement and all textual references to such Exhibit in the Repurchase Agreement are hereby deleted.

SECTION 2.Fees and Expenses. Seller agrees to pay to Purchaser all fees and out of pocket expenses incurred by Purchaser and Agent in connection with this Amendment, including all reasonable fees and out of pocket costs and expenses of the legal counsel to Purchaser and Agent incurred in connection with this Amendment, in accordance with Section 23(a) of the Repurchase Agreement.
SECTION 3.Defined Terms.  Any terms capitalized but not otherwise defined herein should have the respective meanings set forth in the Repurchase Agreement.
SECTION 4.Conditions to Effectiveness of this Amendment.  This Amendment shall become effective on the day (the “Effective Date”) when Seller shall have paid or delivered, as applicable, to Purchaser all of the following fees, expenses, documents and instruments, each of which shall be in form and substance acceptable to Purchaser:
(a)    all accrued and unpaid fees and expenses owed to Purchaser in accordance with the Facility Documents, in each case, in immediately available funds, and without deduction, set-off or counterclaim; 

(b)    a copy of this Amendment duly executed by each of the parties hereto;
 
(c)    a copy of (i) the Amendment Number Eight to the Second Amended and Restated Master Repurchase Agreement Pricing Side Letter, dated as of the date hereof, duly executed by each of the parties thereto (the “PSL Amendment”), (ii)  the Amendment Number Nineteen to the Mortgage Loan Participation Purchase and Sale Agreement, dated as of the date hereof, (iii) the Amendment Number Sixteen to the Loan and Security Agreement, dated as of the date hereof, and (iv) the Third Amended and Restated Loan and Security Agreement Pricing Side Letter,dated as of the date hereof, in each case duly executed by each of the parties thereto; 

(d)    the first installment of the Renewal Fee (as defined in the PSL Amendment); and

(e)    any other documents reasonably requested by Purchaser or Agent on or prior to the date hereof.

SECTION 5.Limited Effect.  Except as amended hereby, the Repurchase Agreement shall continue in full force and effect in accordance with its terms.  Reference to this Amendment need not be made in the Repurchase Agreement or any other instrument or document executed in connection therewith, or in any certificate, letter or communication issued or made pursuant to, or with respect to, the Repurchase Agreement, any reference in any of such items to the Repurchase Agreement being sufficient to refer to the Repurchase Agreement as amended hereby.
SECTION 6.Representations.  In order to induce Purchaser and Agent to execute and deliver this Amendment, Seller hereby represents to Purchaser and Agent that as of the date hereof, (i) Seller is in full compliance with all of the terms and conditions of the Program Documents and remains bound by the terms thereof, and (ii) no Default or Event of Default has occurred and is continuing under the Program Documents.
SECTION 7.Governing Law.  This Amendment and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the laws of the State of New York, without regard to principles of conflict of laws (other than Sections 5-1401 and 5‐1402 of the New York General Obligations Law which shall be applicable).
SECTION 8.Counterparts.  For the purpose of facilitating the execution of this Amendment, and for other purposes, this Amendment may be executed simultaneously in any number of counterparts.  Each counterpart shall be deemed to be an original, and all such counterparts shall constitute one and the same instrument.  The parties intend that faxed signatures and electronically imaged signatures such as .pdf files shall constitute original signatures and are binding on all parties. The original documents shall be promptly delivered, if requested.
[REMAINDER OF THIS PAGE LEFT INTENTIONALLY BLANK]

IN WITNESS WHEREOF, Purchaser, Agent and Seller have caused their names to be duly signed to this Amendment by their respective officers thereunto duly authorized, all as of the date first above written.
BARCLAYS BANK PLC, 
as Purchaser and Agent
		
	By:  /s/ Anthony Beshara
	  
Name: Anthony Beshara 
Title: Director

NATIONSTAR MORTGAGE LLC, 
as Seller
		
	By:  /s/ Pedro Alvarez
	 

Name: Pedro Alvarez
Title: SVP TreasurerEX-4.4

 Exhibit 4.4 

FOURTH AMENDING AGREEMENT TO 

SECOND AMENDED AND RESTATED TERM LOAN AGREEMENT 

dated as of March 12, 2020 

between 
 CORREVIO
PHARMA CORP. 
 as Borrower, 

The Subsidiary Guarantors from Time to Time Party Hereto, 

The Lenders from Time to Time Party Hereto, 

and 
 CRG SERVICING LLC

 as Administrative and Collateral Agent 

  
 - 2 - 

 

 FOURTH AMENDING AGREEMENT TO THE SECOND AMENDED AND RESTATED TERM LOAN AGREEMENT, dated as
of March 12, 2020 (this “Amending Agreement”) among Correvio Pharma Corp., as Borrower, the Subsidiary Guarantors party hereto, the Lenders party hereto and CRG Servicing LLC, as Administrative Agent. 

RECITALS 
 WHEREAS the Borrower,
the Subsidiary Guarantors, the Lenders and the Administrative Agent are parties to the Second Amended and Restated Term Loan Agreement dated as of May 15, 2018 (as amended by amending agreements dated as of March 11, 2019, September 27,
2019 and December 17, 2019 the “Credit Agreement”); 
 AND WHEREAS the Borrower, the Subsidiary Guarantors, the
Lenders and the Administrative Agent have agreed to amend certain provisions of the Credit Agreement in the manner and on the terms and conditions provided for herein. 

NOW THEREFORE for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto
agree as follows: 
 ARTICLE 1 

DEFINITIONS 
  

	1.1	 Definitions 

All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Credit Agreement. 

ARTICLE 2 
 AMENDMENTS

  

	2.1	 Amendments to Credit Agreement 

 

	1)	 Section 1.01 of the Credit Agreement is hereby amended by adding the following definitions in the
applicable alphabetical order: 

 “Definitive Purchase Agreement”
means a purchase agreement for the purchase of all of the outstanding shares of the Borrower that results in the payout in full of all Obligations owing to the Lenders and is in a form, and with a purchaser, satisfactory to the Administrative
Agent. 
 “Fourth Amendment
Effective Date” means, March 12, 2020. 

“Liquidity Covenant Waiver
Period” means, the period commencing on the Fourth Amendment Effective Date and ending on the date that is ten (10) days following the Fourth Amendment Effective Date; provided that if the Borrower
provides the Administrative Agent with an executed Definitive Purchase Agreement during such ten (10) day period and the Administrative Agent confirms in writing to the Borrower that such Definitive Purchase Agreement is acceptable to the
Administrative Agent, then the Liquidity Covenant Waiver Period shall end on the earlier to occur of: (a) June 30, 2020; and (b) the termination of the Definitive Purchase Agreement. 

  
 - 3 - 

 

	2)	 Section 10.01 of the Credit Agreement is hereby deleted and replaced with the following:

 10.01 Minimum Liquidity. The Obligors shall maintain at all times
Liquidity (which for certainty shall exclude amounts in the Italian Account and the Escrow Account) in an aggregate amount which shall exceed (i) $5,000,000 from the date hereof to and including December 31, 2018, (ii) $10,000,000 beginning
January 1, 2019 until the commencement of the Liquidity Covenant Waiver Period, (iii) $0 during the Liquidity Covenant Waiver Period, and (iv) $10,000,000 following the conclusion of the Liquidity Covenant Waiver Period and thereafter. 

 

	3)	 Subsection 10.02(d) of the Credit Agreement is hereby amended by replacing the reference to
“$36,000,000” in such subsection with a reference to “$32,000,000”. 

 ARTICLE 3 

CONDITIONS PRECEDENT 
  

	3.1	 Conditions Precedent 

This Amending Agreement shall become effective if and when: 
  

	 	(a)	 the Administrative Agent shall have received this Amending Agreement duly executed and delivered by the
Administrative Agent, the Lenders, the Borrower and the Subsidiary Guarantors; 

  

	 	(b)	 no Event of Default shall have occurred and be continuing; and 

 

	 	(c)	 the Borrower shall have paid all fees and expenses (including legal fees) owing to the Administrative Agent
and the Lenders as of the date of this Amending Agreement. 

 ARTICLE 4 

REPRESENTATIONS AND WARRANTIES 
  

	4.1	 Representations and Warranties True and Correct; No Default or Event of Default

 Each Obligor hereby represents and warrants to the Administrative Agent and the Lenders that after giving effect to
this Amending Agreement, (i) each of the representations and warranties of the Obligors contained in the Credit Agreement and each of the other Loan Documents is true and correct on, and as of the date hereof as if made on such date (except to
the extent that such representation or warranty expressly relates to an earlier date and except for changes therein expressly permitted or expressly contemplated by the Credit Agreement) and (ii) no event has occurred and is continuing which
constitutes or would constitute a Default or an Event of Default. 

  
 - 4 - 

 

 ARTICLE 5 

SUBSIDIARY GUARANTOR CONFIRMATION 
  

	5.1	 Subsidiary Guarantor Confirmation 

Each Subsidiary Guarantor acknowledges and agrees that each Guarantee to which it is a party continues to be valid and enforceable against
such Subsidiary Guarantor in accordance with its terms and continues to guarantee the obligations set out therein. Further, in connection with the Credit Agreement as amended by this Amending Agreement, each Subsidiary Guarantor hereby ratifies,
confirms, acknowledges and agrees that such Subsidiary Guarantor is and continues to be bound by all of the obligations, indebtedness and liabilities of, and grants of security made by, such Subsidiary Guarantor under the Loan Documents to which
each is a party. 
 ARTICLE 6 

MISCELLANEOUS 
  

	6.1	 No Other Amendments, Waivers or Consents 

Except as expressly set forth herein, the Credit Agreement and all Credit Documents shall be unmodified and shall continue to be in full force
and effect in accordance with their terms. The execution, delivery and effectiveness of the waiver and amendments in this Amending Agreement shall not be deemed to be a waiver of compliance in the future or a waiver of any preceding or succeeding
breach of any covenant or provision of the Credit Agreement. 
  

	6.2	 Time 

Time is of the essence in the performance of the parties’ respective obligations in this Amending Agreement. 

 

	6.3	 Governing Law 

This Amending Agreement and the rights and obligations of the parties hereunder shall be governed by, and construed in accordance with, the
law of the State of New York, without regard to principles of conflicts of laws that would result in the application of the laws of any other jurisdiction; provided that Section 5-1401 of the New York
General Obligations Law shall apply. 
  

	6.4	 Successors and Assigns 

This Amending Agreement shall enure to the benefit of and be binding upon the parties hereto and their respective successors and any assigns,
transferees and endorsees of the Administrative Agent or any Lender. Nothing in this Amending Agreement, express or implied, shall give to any Person, other than the parties hereto and their successors hereunder, any benefit or any legal or
equitable right, remedy or claim under this Amending Agreement. 
  

	6.5	 Counterparts 

This Amending Agreement may be executed by the parties hereto in counterparts and may be executed and delivered by facsimile or other
electronic means and all such counterparts and facsimiles shall together constitute one and the same agreement. 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered as of the day and year first above written. 
  

			
	 BORROWER:

		
		 	 CORREVIO PHARMA CORP.

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title: CFO and President

		
	 By:
	 	 
		 	 Name:

		 	 Title:

		
		 	 Address for Notices:

Correvio Pharma Corp.
 1441
Creekside Drive,
 6th Floor

Vancouver, BC V6J 4S7
 Canada

 
 Attn: Legal Affairs

Tel.: (604) 677-6905
 Fax: (604) 677-6915
 Email: contracts@correvio.com

 Signature Page to Fourth Amending Agreement 

 SUBSIDIARY GUARANTORS: 

 

			
	 CARDIOME, INC.

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title: Director

		
		 	 Address for Notices:

c/o Corporation Service Company

2711 Centerville Road
 Suite
400
 Wilmington, DE 19808 USA
  

with a copy to:
 c/o Correvio
Pharma Corp.
 1441 Creekside Drive

6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs
 Tel.: (604) 677-6905
 Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 
			
	 ARTESIAN THERAPEUTICS, INC.

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title:   Director

 

		 	 Address for Notices:

c/o Corporation Service Company

2711 Centerville Road

Suite 400

Wilmington, DE 19808 USA
  

with a copy to:

c/o Correvio Pharma Corp.

1441 Creekside Drive

6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs

Tel.: (604) 677-6905

Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 
			
	 CORREVIO LLC

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title:   CFO

		
	 By:
	 	 
		 	 Name:

		 	 Title:
  

Address for Notices:
 Correvio
LLC
 3 Dickinson Drive
 Suite
101
 Chadds Ford, PA 19317 USA
  

with a copy to:
 c/o Correvio
Pharma Corp.
 1441 Creekside Drive

6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs
 Tel.: (604) 677-6905
 Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 
			
	 CORREVIO INTERNATIONAL SARL

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title:   Director

		
	 By:
	 	 
		 	 Name:

		 	 Title:
  

Address for Notices:
 Rue des
Alpes 21
 1201 Geneva Switzerland
  

with a copy to:
 c/o Correvio
Pharma Corp.
 1441 Creekside Drive

6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs
 Tel.: (604) 677-6905
 Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 
			
	 CORREVIO (UK) LTD.

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title:   Director

		
	 By:
	 	 
		 	 Name:

		 	 Title:
  

Address for Notices:
 Lakeside
House
 1 Furzeground Way,

Stockley Park,
 Uxbridge,
Middlesex,
 UB11 1BD
 United
Kingdom
  
 with a copy to:

c/o Correvio Pharma Corp.
 1441
Creekside Drive
 6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs
 Tel.: (604) 677-6905
 Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 
			
	 CARDIOME UK LIMITED

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title:   Director

		 	  
 Address for Notices:

Lakeside House
 1 Furzeground
Way,
 Stockley Park,
 Uxbridge,
Middlesex,
 UB11 1BD
 United
Kingdom
  
 with a copy to:

c/o Correvio Pharma Corp.
 1441
Creekside Drive
 6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs
 Tel.: (604) 677-6905
 Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 
			
	 CORREVIO GMBH

		
	 By:
	 	 /s/ Justin Renz

		 	 Name: Justin Renz

		 	 Title:   Director

		
	 By:
	 	 
		 	 Name:

		 	 Title:
  

Address for Notices:
 Nikolaus
Durkopp Str. 4A
 33602 Bielefeld Germany
  

with a copy to:
 c/o Correvio
Pharma Corp.
 1441 Creekside Drive

6th Floor

Vancouver, BC V6J 4S7 Canada
  

Attn: Legal Affairs
 Tel.: (604) 677-6905
 Fax: (604) 677-6915

Email: legalaffairs@cardiome.com

 Signature Page to Fourth Amending Agreement 

 ADMINISTRATIVE AGENT: 

 

			
	 CRG SERVICING LLC

		
	 By:
	 	 /s/ Nathan Hukill

		 	 Name: Nathan Hukill

		 	 Title:   Authorized Signatory

		 	  
 Address for Notices:

1000 Main Street
 Suite 2500

Houston, TX 77002
  

Attn: General Counsel
 Tel.: (713)
209-7350
 Fax: (713) 209-7351

Email: adorenbaum@crglp.com

 Signature Page to Fourth Amending Agreement 

 LENDERS: 

 

			
	 CRG PARTNERS III L.P.
 By CRG
PARTNERS III GP L.P., its General Partner
 By CRG PARTNERS III GP LLC, its General Partner

		
	By:	 	/s/ Nathan Hukill
		 	Name: Nathan Hukill
		 	 Title:   Authorized Signatory
  

		 	 Address for Notices:
 1000 Main Street

Suite 2500
 Houston, TX 77002

 
 Attn: General Counsel

Tel.: (713) 209-7350
 Fax:
(713) 209-7351
 Email: adorenbaum@crglp.com

  

			
	 CRG PARTNERS III – PARALLEL FUND “A” L.P.

By CRG PARTNERS III – PARALLEL FUND “A” GP L.P., its General Partner

By CRG PARTNERS III – PARALLEL FUND “A” GP LLC, its General Partner

		
	By:	 	/s/ Nathan Hukill
		 	Name: Nathan Hukill
		 	 Title:   Authorized Signatory
  

		 	 Address for Notices:
 1000 Main Street

Suite 2500
 Houston, TX 77002

 
 Attn: General Counsel

Tel.: (713) 209-7350
 Fax:
(713) 209-7351
 Email: adorenbaum@crglp.com

 Signature Page to Fourth Amending Agreement 

 
			
	 CRG PARTNERS III (CAYMAN) L.P.
 By
CRG PARTNERS III (CAYMAN) GP L.P., its General Partner
 By CRG PARTNERS III (CAYMAN) GP LLC, its General Partner

		
	By:	 	/s/ Nathan Hukill
		 	Name: Nathan Hukill
		 	 Title:   Authorized Signatory
  

		 	 Address for Notices:
 1000 Main Street

Suite 2500
 Houston, TX 77002

 
 Attn: General Counsel

Tel.: (713) 209-7350
 Fax:
(713) 209-7351
 Email: adorenbaum@crglp.com

  

			
	 CRG PARTNERS III – PARALLEL FUND “B” (CAYMAN) L.P.

By CRG PARTNERS III (CAYMAN) GP L.P., its General Partner
 By CRG
PARTNERS III (CAYMAN) GP LLC, its General Partner

		
	By:	 	/s/ Nathan Hukill
		 	Name: Nathan Hukill
		 	 Title:   Authorized Signatory
  

		 	 Address for Notices:
 1000 Main Street

Suite 2500
 Houston, TX 77002

 
 Attn: General Counsel

Tel.: (713) 209-7350
 Fax:
(713) 209-7351
 Email: adorenbaum@crglp.com

 Signature Page to Fourth Amending Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]